CART (85-102)-inhibition of psychostimulant-induced hyperlocomotion: importance of cyclization

Peptides. 2006 Dec;27(12):3183-92. doi: 10.1016/j.peptides.2006.09.009. Epub 2006 Nov 7.

Abstract

Synthetic derivative of C-terminal fragment of CART (55-102) with reduced thiol groups, [Abu(86,94)]CART (85-102)(red), given together with amphetamine (5 mg/kg, s.c.) or cocaine (15 mg/kg, s.c.), reversed hyperlocomotion induced by these drugs at a dose of 0.1 microg but not at a higher dose. In the cerebral cortex homogenate, [Abu(86,94)]CART (85-102)(red) was nonspecifically cleaved from N- and C-termini. This peptide contains two chemically blocked Cys residues, and two others in reduced form. Concomitant with cleavage, rapid cyclization occurred. The newly formed cyclic peptides were stable. The cyclic peptide [Abu(86,94)]CART (85-102)(ox) failed to inhibit amphetamine- and cocaine-induced locomotor activity. The ability to inhibit the locomotor-stimulant activity of amphetamine was retained in [Abu(86,88,94,101)]CART (85-102), in which all Cys were replaced with 2-aminobutyric acid to prevent their pairing. Disulfide bridge formation may be an interesting mechanism that prevents proteolysis of [Abu(86,94)]CART (85-102)(red) and terminates its ability to reverse amphetamine-induced hyperlocomotion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphetamines / pharmacology
  • Animals
  • Cocaine / pharmacology
  • Cystine / genetics
  • Cystine / metabolism
  • Locomotion / drug effects*
  • Locomotion / physiology*
  • Male
  • Mice
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / physiology*
  • Peptide Fragments / genetics
  • Peptide Fragments / physiology*
  • Psychotropic Drugs / pharmacology*
  • Rats
  • Structure-Activity Relationship

Substances

  • Amphetamines
  • Nerve Tissue Proteins
  • Peptide Fragments
  • Psychotropic Drugs
  • cocaine- and amphetamine-regulated transcript protein
  • Cystine
  • Cocaine